Literature DB >> 2416534

Photosensitivity as a model for acute antiepileptic drug studies.

C D Binnie, D G Kasteleijn-Nolst Trenité, R De Korte.   

Abstract

A technique is described for assessing the efficacy and time course of effects of antiepileptic drugs, after a single acute dose, by means of their action on the human photo-convulsive response. The range of frequencies of intermittent photic stimulation to which the patient is sensitive (photosensitivity range) is determined in a standardized manner at hourly intervals over the course of a waking day. 82 controlled studies have established that, with the rare exceptions of patients showing a consistent circadian rhythm of photosensitivity, the photosensitivity range is stable over this time scale. A total of 72 studies have shown that representatives of all the major groups of established antiepileptic drugs, together with some experimental drugs, suppress photosensitivity following a single acute administration. By contrast barbiturates without antiepileptic action (methohexitone and quinalbarbitone) do not affect photosensitivity even in doses producing marked drowsiness. These findings suggest the technique to be a potentially useful tool for preliminary investigation of efficacy and duration of action of new potential antiepileptic drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2416534     DOI: 10.1016/0013-4694(86)90060-x

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  8 in total

1.  Contrast gain control abnormalities in idiopathic generalized epilepsy.

Authors:  Jeffrey J Tsai; Anthony M Norcia; Justin M Ales; Alex R Wade
Journal:  Ann Neurol       Date:  2011-06-27       Impact factor: 10.422

2.  Preliminary evaluation of potential anti-epileptic drugs by single dose electrophysiological and pharmacological studies in patients.

Authors:  C D Binnie
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

3.  Effects of marketed antiepileptic drugs and placebo in the human photosensitivity screening protocol.

Authors:  Jacqueline A French; Gregory L Krauss; Dorothee Kasteleijn; Bree D DiVentura; Emilia Bagiella
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 4.  Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.

Authors:  A Fitton; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 5.  Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going?

Authors:  Aaron C Gerlach; Jeffrey L Krajewski
Journal:  Pharmaceuticals (Basel)       Date:  2010-09-01

6.  Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089).

Authors:  Dorothee G A Kasteleijn-Nolst Trenite; Bree D DiVentura; John R Pollard; Gregory L Krauss; Sarah Mizne; Jacqueline A French
Journal:  Neurology       Date:  2019-07-10       Impact factor: 9.910

7.  Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients.

Authors:  Ronald C Reed; William E Rosenfeld; Susan M Lippmann; Rene M J C Eijkemans; Dorothee G A Kasteleijn-Nolst Trenité
Journal:  CNS Drugs       Date:  2020-10       Impact factor: 5.749

8.  Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy.

Authors:  Dorotheé G A Kasteleijn-Nolst Trenité; Victor Biton; Jacqueline A French; Bassel Abou-Khalil; William E Rosenfeld; Bree Diventura; Elizabeth L Moore; Seth V Hetherington; Greg C Rigdon
Journal:  Epilepsia       Date:  2013-05-20       Impact factor: 5.864

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.